verapamil has been researched along with 17 alpha-hydroxyprogesterone caproate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Caritis, SN; Dorko, K; Ellis, EC; Gramignoli, R; Hansel, M; Hines, RN; Mattison, DR; Sharma, S; Strom, SC; Tahan, V; Venkataramanan, R | 1 |
1 review(s) available for verapamil and 17 alpha-hydroxyprogesterone caproate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for verapamil and 17 alpha-hydroxyprogesterone caproate
| Article | Year |
|---|---|
Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytes.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Age Factors; Aged; Biological Transport; Cells, Cultured; Cold Temperature; Cyclosporine; Female; Gestational Age; Hepatocytes; Humans; Hydroxyprogesterones; Kinetics; Male; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Protein 2; Rifampin; RNA, Messenger; Taurocholic Acid; Verapamil; Young Adult | 2013 |